# Church & Dwight Co Inc: Form 10-Q for the period ended Sep 30, 2017

- Company: [Church & Dwight Co Inc](/companies/chd.md) (CIK 313927)
- Form: 10-Q
- Filed: 2017-11-02
- Accepted by EDGAR: Nov 2, 2017, 16:53 ET
- Period: 2017-09-30
- Accession: 0001564590-17-021066
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/313927/000156459017021066/chd-10q_20170930.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/313927/000156459017021066/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2017-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Gross profit | 3 months, 2017-07-01 to 2017-09-30 | $438.5m | us-gaap:GrossProfit |
| Gross profit | 9 months, 2017-01-01 to 2017-09-30 | $1.25bn | us-gaap:GrossProfit |
| Research and development | 3 months, 2017-07-01 to 2017-09-30 | $18.0m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months, 2017-01-01 to 2017-09-30 | $48.1m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2017-07-01 to 2017-09-30 | $127.9m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months, 2017-01-01 to 2017-09-30 | $396.6m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2017-07-01 to 2017-09-30 | $198.7m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2017-01-01 to 2017-09-30 | $518.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2017-07-01 to 2017-09-30 | $16.4m | us-gaap:InterestExpense |
| Interest expense | 9 months, 2017-01-01 to 2017-09-30 | $33.9m | us-gaap:InterestExpense |
| Income tax | 3 months, 2017-07-01 to 2017-09-30 | $53.6m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2017-01-01 to 2017-09-30 | $156.2m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2017-07-01 to 2017-09-30 | $133.4m | us-gaap:ProfitLoss |
| Net income | 9 months, 2017-01-01 to 2017-09-30 | $337.8m | us-gaap:ProfitLoss |
| Diluted EPS | 3 months, 2017-07-01 to 2017-09-30 | $0.52 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2017-01-01 to 2017-09-30 | $1.32 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2017-07-01 to 2017-09-30 | $0.53 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2017-01-01 to 2017-09-30 | $1.34 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2017-07-01 to 2017-09-30 | 255,300,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2017-01-01 to 2017-09-30 | 256,900,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Capital expenditure | 9 months, 2017-01-01 to 2017-09-30 | $20.9m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months, 2017-01-01 to 2017-09-30 | $143.2m | us-gaap:PaymentsOfDividends |
| Share repurchases | 9 months, 2017-01-01 to 2017-09-30 | $300.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2017-09-30 | $236.5m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2017-09-30 | $1.00bn | us-gaap:AssetsCurrent |
| Total assets | at 2017-09-30 | $5.95bn | us-gaap:Assets |
| Current liabilities | at 2017-09-30 | $952.6m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2017-09-30 | $4.00bn | us-gaap:Liabilities |
| Long-term debt | at 2017-09-30 | $2.10bn | us-gaap:LongTermDebtNoncurrent |
| Short-term borrowings | at 2017-09-30 | $317.2m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | at 2017-09-30 | $1.95bn | us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest |

## Management's discussion and analysis

As filed, 31,047 characters.

### RESULTS OF OPERATIONS

#### Recent Developments

#### Water Pik, Inc. Acquisition

On August 7, 2017, the Company acquired Pik Holdings, Inc. (“Waterpik”), a water-jet technology company that designs and sells both oral water flossers and replacement shower heads (the “Waterpik Acquisition”). The total purchase price was $1,024.7 (net of cash acquired), which is subject to a working capital adjustment. Waterpik’s annual sales were approximately $265.0 for the trailing twelve months through June 30, 2017. The Company financed the Waterpik Acquisition with proceeds from its underwritten public offering of $1,425.0 aggregate principal amount of Senior Notes (as defined below) completed on July 25, 2017. Subsequent to the Waterpik Acquisition, Waterpik is managed by the Consumer Domestic and Consumer International segments.

### Results of Operations

### Consolidated results

|  | Three Months Ended September 30, 2017 | Change vs. Prior Year | Three Months Ended September 30, 2016 |
| --- | ---: | ---: | ---: |
| **Net Sales** | **$967.9** | 11.2% | $870.7 |
| **Gross Profit** | **$438.5** | 10.8% | $395.6 |
| Gross Margin | **45.3%** | -10 basis points | 45.4% |
| **Marketing Expenses** | **$111.9** | 14.0% | $98.2 |
| Percent of Net Sales | **11.6%** | +30 basis points | 11.3% |
| **Selling, General & Administrative Expenses** | **$127.9** | 26.1% | $101.4 |
| Percent of Net Sales | **13.2%** | +160 basis points | 11.6% |
| **Income from Operations** | **$198.7** | 1.4% | $196.0 |
| Operating Margin | **20.5%** | -200 basis points | 22.5% |
| **Net income per share - Diluted** | **$0.52** | 10.6% | $0.47 |
|  | **Nine Months Ended** | **Change vs.** | **Nine Months Ended** |
|  | **September 30, 2017** | **Prior Year** | **September 30, 2016** |
| **Net Sales** | **$2,743.1** | 5.6% | $2,597.1 |
| **Gross Profit** | **$1,248.2** | 5.5% | $1,182.6 |
| Gross Margin | **45.5%** | 0 basis points | 45.5% |
| **Marketing Expenses** | **$333.6** | 7.3% | $310.9 |
| Percent of Net Sales | **12.2%** | +20 basis points | 12.0% |
| **Selling, General & Administrative Expenses** | **$396.6** | 23.6% | $320.9 |
| Percent of Net Sales | **14.4%** | +210 basis points | 12.3% |
| **Income from Operations** | **$518.0** | -6.0% | $550.8 |
| Operating Margin | **18.9%** | -230 basis points | 21.2% |
| **Net income per share - Diluted** | **$1.32** | -0.8% | $1.33 |

During the third quarter of 2017, the Company reversed a tax valuation allowance of $7.6 ($0.03 per share) established in 2015 in connection with the impairment of its remaining investment in Natronx. In the second quarter of 2017, the Company settled an international defined benefit plan, resulting in a pre-tax charge recorded in selling, general and administrative expenses of $39.2 ($31.5 after tax or $0.12 per share). During the first quarter of 2017, the Company closed the previously announced sale of its chemical business in Brazil. As a result, a pre and post- tax charge of $3.5 was recorded ($1.3 in cost of goods sold and $2.2 in selling, general and administrative expenses). This equated to $0.01 per share. Also during the first quarter, the Company adopted a new accounting standard related to certain aspects of share-based payment awards to employees. This standard requires that any excess tax benefits related to share-based payment awards to employees be recorded as a reduction to income tax expense. Previously, this benefit was recorded in the stockholders’ equity section of the Balance Sheet. The amount recorded in the three and nine months ended September 30, 2017 as a reduction to income tax expense was $3.5 ($0.01 per share) and $14.6 ($0.05 per share), respectively.

#### Net Sales

Net sales for the quarter ended September 30, 2017 were $967.9, an increase of $97.2 or 11.2% as compared to the same period in 2016. Net sales for the nine months ended September 30, 2017 were $2,743.1, an increase of $146.0 or 5.6% over the comparable nine month period of 2016. The components of the net sales increase are as follows:

| Net Sales - Consolidated | Three Months Ended September 30, 2017 | Nine Months Ended September 30, 2017 |
| --- | ---: | ---: |
| Product volumes sold | 6.9% | 5.2% |
| Pricing/Product mix | (3.7)% | (2.8)% |
| Foreign exchange rate fluctuations | 0.5% | (0.2)% |
| Volume from acquired product lines (net of divestiture) (1) | 7.5% | 3.4% |
| **Net Sales increase** | **11.2%** | **5.6%** |

(1) On December 22, 2016, the Company acquired the ANUSOL and RECTINOL business (the “Anusol Acquisition”). On January 17, 2017, the Company acquired the VIVISCAL business (the “Viviscal Acquisition”). On May 1, 2017, the Company acquired Agro BioSciences, Inc. (the “Agro Acquisition”). On August 7, 2017, the Company acquired Waterpik (the “Waterpik Acquisition”). Net sales of these acquisitions are included in the Company’s results since the date of acquisition. In March 2017, the Company sold its chemical business in Brazil.

#### Gross Profit / Gross Margin

The Company’s gross profit was $438.5 for the quarter ended September 30, 2017, a $42.9 increase as compared to the same period in 2016. Gross margin decreased 10 basis points (“bps”) in the third quarter of 2017 compared to the same period in 2016, primarily due to unfavorable price/mix of 200 bps (primarily due to higher promotion and coupon costs), higher commodity costs of 30 bps, and the impact of unfavorable foreign exchange rates of 10 bps, partially offset by the impact of higher margins on acquired businesses representing 100 bps, favorable volume of 100 bps and cost improvement projects representing 30 bps. Gross profit was $1,248.2 for the nine months ended September 30, 2017, a $65.6 increase compared to the same period of 2016. Gross margin for the first nine months of 2017 and 2016 was 45.5%. Gross margin remained consistent for the first nine months of 2017 compared to the same period in 2016, primarily due to unfavorable price/mix of 160 bps (primarily due to higher promotion and coupon costs), higher commodity costs of 30 bps and the impact of unfavorable foreign exchange rates of 10 bps, offset by the impact of higher margins on acquired businesses representing 80 bps, favorable volume of 70 bps and cost improvement projects representing 50 bps.

#### Operating Expenses

Marketing expenses for the third quarter of 2017 were $111.9, an increase of $13.7 or 14.0% as compared to the same period in 2016. Acquired businesses contributed modestly to the increase. Marketing expenses as a percentage of net sales in the third quarter of 2017 increased 30 bps to 11.6% as compared to 11.3% in 2016 due to 140 bps on higher expenses partially offset by 110 bps of leverage on higher net sales. Marketing expenses for the first nine months of 2017 were $333.6, an increase of $22.7 as compared to the same period in 2016. Marketing expenses as a percentage of net sales for the nine months of 2017 increased by 20 bps to 12.2% as compared to 12.0% in 2016 due to 80 bps on higher expenses partially offset by 60 bps of leverage on higher net sales.

Selling, general and administrative (“SG&A”) expenses were $127.9 in the third quarter of 2017, an increase of $26.5 or 26.1% as compared to the same period in 2016 which was significantly impacted by transition and ongoing costs associated with the Viviscal, Anusol, Agro, and Waterpik acquisitions, along with higher research and development costs. SG&A as a percentage of net sales increased 160 bps to 13.2% in the third quarter of 2017 as compared to 11.6% in the same period in 2016. The increase is due to higher costs of 280 bps primarily associated with the Viviscal, Anusol, Agro and Waterpik acquisitions, partially offset by 120 bps of leverage associated with higher sales. SG&A for the first nine months of 2017 was $396.6, an increase of $75.7 as compared to the same period in 2016. The increase is primarily due to the $39.2 international pension settlement charge or 140 bps in 2017, transition and ongoing acquisition-related costs, higher information system and legal costs and costs associated with selling the chemical business in Brazil. SG&A as a percentage of net sales increased 210 bps to 14.4% in the first nine months of 2017 compared to 12.3% in 2016 due to higher costs, including pension settlement expense of 280 bps partially offset by 70 bps of leverage associated with higher sales.

#### Other Income and Expenses

Equity in earnings of affiliates for the three and nine months ended September 30, 2017 increased by $0.2 and $1.2, respectively, as compared to the same periods in 2016, primarily due to profit improvement from Armand Products due to lower raw material costs.

Other income, net for the three months ended September 30, 2017 increased $0.9 compared to the same period in 2016 primarily due to the effect of changes in foreign exchange rates and increased $2.0 for the nine months ended September 30, 2017 compared to the same period in 2016 due to the impact of costs incurred in 2016 associated with the Natronx Technologies, LLC (“Natronx”) joint venture.

Interest expense for the three and nine month periods ended September 30, 2017 increased $9.6 and $13.2 as compared to the same periods in 2016 due to a higher amount of average debt outstanding associated with the $1,425.0 aggregate principal amount of Senior Notes completed on July 25, 2017.

#### Income Taxes

The effective tax rate for the three months ended September 30, 2017 was 28.7% compared to 35.6% in the same period in 2016. The decrease in the tax rate is primarily due to the reversal of a valuation allowance against the tax benefit related to the Natronx impairment charge recorded in 2015 representing 400 bps and a tax benefit of 180 bps related to the adoption of the new accounting standard which modifies how companies account for certain aspects of share-based payment awards to employees. Previously, this tax benefit related to the adoption of the new accounting standard was accounted for in the Company’s Stockholders’ Equity section of the Balance Sheet. Starting in 2017, the tax benefit has been accounted for as a reduction of income tax expense.

The effective tax rate for the nine months ended September 30, 2017 was 31.6% compared to 35.0% in the same period in 2016. The decrease in the tax rate is primarily due to the impact of the new accounting standard relating to share based payment awards representing 300 bps and the reversal of the Natronx valuation allowance representing 150 bps, partially offset by the international pension settlement charge representing 90 bps.

### Segment results

The Company operates three reportable segments: Consumer Domestic, Consumer International and SPD. These segments are determined based on differences in the nature of products and organizational and ownership structures. The Company also has a Corporate segment.

| Segment | Products |
| --- | --- |
| Consumer Domestic | Household and personal care products |
| Consumer International | Primarily personal care products |
| SPD | Specialty chemical products |

The Corporate segment income consists of equity in earnings of affiliates. As of September 30, 2017, the Company held 50% ownership interests in each of Armand Products Company (“Armand”) and The ArmaKleen Company (“ArmaKleen”), respectively, and a one-third ownership interest in Natronx. The Company’s equity in earnings of Armand and ArmaKleen for the three and nine month periods ended September 30, 2017 and 2016 are included in the Corporate segment.

Certain subsidiaries that are included in the Consumer International segment manufacture and sell personal care products to the Consumer Domestic segment. These sales are eliminated from the Consumer International segment results set forth below.

Segment net sales and income before income taxes for the three and nine month periods ended September 30, 2017 and September 30, 2016 are as follows:

| Net Sales(1) | Consumer Domestic | Consumer International | SPD | Corporate(3) | Total |
| --- | ---: | ---: | ---: | ---: | ---: |
| **Third Quarter 2017** | **$729.2** | **$162.8** | **$75.9** | **$0.0** | **$967.9** |
| Third Quarter 2016 | 664.8 | 133.8 | 72.1 | 0.0 | 870.7 |
| **First Nine Months of 2017** | **$2,067.1** | **$451.0** | **$225.0** | **$0.0** | **$2,743.1** |
| First Nine Months of 2016 | 1,982.4 | 397.6 | 217.1 | 0.0 | 2,597.1 |
| **Income before Income Taxes(2)** |  |  |  |  |  |
| **Third Quarter 2017** | **$146.9** | **$23.6** | **$13.8** | **$2.7** | **$187.0** |
| Third Quarter 2016 | 160.2 | 19.8 | 9.9 | 2.5 | 192.4 |
| **First Nine Months of 2017(3)** | **$431.5** | **$19.3** | **$35.3** | **$7.9** | **$494.0** |
| First Nine Months of 2016 | 441.7 | 54.1 | 33.9 | 6.7 | 536.4 |

(1) Intersegment sales from Consumer International to Consumer Domestic, which are not reflected in the table, were $1.5 and $1.0 for the three months ended September 30, 2017 and September 30, 2016, respectively, and were $4.2 and $3.0 for the nine months ended September 30, 2017 and September 30, 2016, respectively.

(2) In determining Income before Income Taxes, interest expense and investment earnings were allocated among the segments based upon each segment’s relative Income from Operations.

(3) Includes a pension settlement charge of $39.2 recorded in Consumer International.

Product line revenues from external customers are as follows:

|  | Three Months Ended September 30, 2017 | September 30, 2016 | Nine Months Ended September 30, 2017 | September 30, 2016 |
| --- | ---: | ---: | ---: | ---: |
| Household Products | **$423.3** | $400.7 | **$1,228.6** | $1,186.8 |
| Personal Care Products | **305.9** | 264.1 | **838.5** | 795.6 |
| Total Consumer Domestic | **729.2** | 664.8 | **2,067.1** | 1,982.4 |
| Total Consumer International | **162.8** | 133.8 | **451.0** | 397.6 |
| Total SPD | **75.9** | 72.1 | **225.0** | 217.1 |
| **Total Consolidated Net Sales** | **$967.9** | $870.7 | **$2,743.1** | $2,597.1 |

Household Products include laundry, deodorizing, and cleaning products. Personal Care Products include condoms, pregnancy kits, oral care products, skin care and hair care products and gummy dietary supplements.

### Consumer Domestic

Consumer Domestic net sales in the third quarter of 2017 were $729.2, an increase of $64.4 or 9.7% as compared to the same period in 2016. Consumer Domestic net sales for the nine months ended September 30, 2017 were $2,067.1, an increase of $84.7 or 4.3% as compared to the same period in 2016. The components of the net sales change are the following:

| Net Sales - Consumer Domestic | Three Months Ended September 30, 2017 | Nine Months Ended September 30, 2017 |
| --- | ---: | ---: |
| Product volumes sold | 7.1% | 4.9% |
| Pricing/Product mix | (4.9%) | (3.9%) |
| Volume from acquired product lines (1) | 7.5% | 3.3% |
| **Net Sales increase** | **9.7%** | **4.3%** |

(1) Includes net sales of the brands acquired in the Viviscal Acquisition and the Waterpik Acquisition since the date of acquisition.

The increase in net sales for the three months ended September 30, 2017, reflects the impact of acquisitions, higher sales of ARM & HAMMER liquid detergent, cat litter and baking soda, BATISTE dry shampoo, OXICLEAN stain fighters and ORAJEL, partially offset by lower sales of XTRA laundry detergent and VITAFUSION and L’IL CRITTERS gummy vitamins. The increase in net sales for the nine month period ending September 30, 2017, reflects the impact of acquisitions, higher sales of ARM & HAMMER liquid and unit dose detergents, BATISTE dry shampoo, OXICLEAN laundry detergent and stain fighters and ARM & HAMMER cat litter, partially offset by lower sales of TROJAN condoms, XTRA laundry detergent and VITAFUSION and L’IL CRITTERS gummy vitamins.

There continues to be significant product and price competition in the laundry detergent category. For example, the Procter & Gamble Company markets a lower-priced line of laundry detergents that competes directly with the Company’s core value laundry detergents. Henkel AG & Co. KGaA (“Henkel”) entered the U.S. market with Persil, its leading worldwide premium laundry detergent, and in 2016 acquired The Sun Products Corporation (“Sun Products”), the maker of ALL, WISK and SUN laundry detergents. These actions have increased price competition and distribution pressures in the premium and extreme value laundry categories and could adversely impact sales and market share of the Company’s laundry brands. The Company continues to evaluate and vigorously combat these pressures through, among other things, new product introductions and increased marketing and trade spending.

The Company tests its indefinite lived intangible assets in the fourth quarter of each year, unless there is a triggering event that warrants review. There is a personal care trade name that, based on recent performance, has experienced sales and profit declines that have eroded a significant portion of the excess between fair and carrying value which could potentially result in an impairment of the asset. In 2016, this excess amounted to approximately $60.0 or 20%. The Company will complete its assessment during the fourth quarter and record or disclose any additional conclusions.

Consumer Domestic income before income taxes for the third quarter of 2017 was $146.9, a $13.3 decrease as compared to the third quarter of 2016. The decrease is due primarily to unfavorable price/mix (consisting of higher promotion and coupon spending) of $33.0, higher SG&A of $14.2, higher marketing expenses of $12.8 and higher interest expense of $7.5, partially offset by the impact of higher sales volumes of $53.7. For the nine month period ended September 30, 2017, income before income taxes was $431.5, a $10.2 decrease as compared to the first nine months of 2016. The decrease is due primarily to unfavorable price/mix (consisting of higher promotion and coupon spending) of $80.5, higher marketing expenses of $18.5, higher SG&A of $11.1 and higher interest expense of $10.6, partially offset by the impact of higher sales volumes of $94.0 and favorable manufacturing costs of $16.8.

### Consumer International

Consumer International net sales were $162.8 in the third quarter of 2017, an increase of $29.0 or 21.7% as compared to the same period in 2016. Consumer International net sales in the first nine months of 2017 were $451.0, an increase of $53.4 or approximately 13.4% as compared to the same period in 2016. The components of the net sales change are the following:

| Net Sales - Consumer International | Three Months Ended September 30, 2017 | Nine Months Ended September 30, 2017 |
| --- | ---: | ---: |
| Product volumes sold | 7.1% | 8.8% |
| Pricing/Product mix | (0.9%) | (0.4%) |
| Foreign exchange rate fluctuations / Other | 3.1% | (1.6)% |
| Volume from acquired product lines (1) | 12.4% | 6.6% |
| **Net Sales increase** | **21.7%** | 13.4% |

(1) Includes net sales of the brands acquired in the Anusol Acquisition, the Viviscal Acquisition and the Waterpik Acquisition since the date of acquisition.

Excluding the impact of foreign exchange rates and acquisitions, higher sales in the third quarter ended September 30, 2017 were primarily due to FEMFRESH, OXICLEAN and STERIMAR in the export business, ARM & HAMMER cat litter and BATISTE in Canada, FEMFRESH in Australia and STERIMAR and ARM & HAMMER baking soda in Mexico. For the nine months ended September 30, 2017, excluding the impact foreign exchange rates and acquisitions, higher sales primarily occurred in exports, Canada, and Mexico, and were attributable to FEMFRESH, BATISTE, STERIMAR, OXICLEAN, and ARM & HAMMER cat litter.

Consumer International income before income taxes was $23.6 in the third quarter 2017, an increase of $3.8 compared to the same period in 2016 due primarily to higher sales volumes of $15.0, partially offset by higher SG&A costs of $9.7 and unfavorable foreign exchange rates of $0.6. For the first nine months of 2017, income before income taxes was $19.3, a $34.8 decrease as compared to the same period in 2016, due primarily to the pension settlement charge of $39.2, higher SG&A costs of $17.8, higher marketing costs of $5.3, unfavorable foreign exchange rates of $3.9, unfavorable manufacturing and commodity costs of $3.2 and unfavorable price/mix of $1.8, partially offset by higher sales volumes of $37.4.

### Specialty Products (“SPD”)

SPD net sales were $75.9 in the third quarter of 2017, an increase of $3.8 or 5.3% as compared to the same period in 2016. SPD net sales were $225.0 for the first nine months of 2017, an increase of $7.9, or 3.6% as compared to the same period of 2016. The components of the net sales change are the following:

| Net Sales - SPD | Three Months Ended September 30, 2017 | Nine Months Ended September 30, 2017 |
| --- | ---: | ---: |
| Product volumes sold | 4.6% | 2.5% |
| Pricing/Product mix | 2.9% | 2.8% |
| Foreign exchange rate fluctuations / Other | (—)% | 0.5% |
| Volume from acquired product lines (net of divestiture) (1) | (2.2)% | (2.2)% |
| **Net Sales increase** | **5.3%** | **3.6%** |

(1) Includes net sales of the Agro Acquisition since the date of acquisition and is negatively impacted by the sale of the Brazilian chemical business.

Excluding the impact of the acquisition and divestiture, the net sales increase in the third quarter and nine month period of 2017 was driven primarily by improved price and volumes in the animal productivity business where U.S. dairy farm profitability remains at a higher level than a year ago.

SPD income before income taxes was $13.8 in the third quarter of 2017, an increase of $3.9 as compared to the same period in 2016 due primarily to higher sales volume of $6.2, favorable price/product mix of $1.9, partially offset by higher SG&A costs of $2.0 and higher manufacturing costs of $1.3. SPD income before income taxes was $35.3 in the first nine months of 2017, an increase of $1.4 as compared to the same period in 2016 due primarily to higher sales volume of $9.7, favorable price/product mix of $5.5, and lower costs associated with the Natronx joint venture of $1.7, partially offset by higher manufacturing costs of $7.2, higher SG&A costs of $4.6 and costs associated with the sale of the Brazilian chemical business of $3.5.

### Corporate

The administrative costs of the Company’s production, planning and logistics functions are included in the SG&A expenses of each operating segment and as elements of cost of sales in the Company’s Condensed Consolidated Statements of Income. The Corporate segment includes equity in earnings of affiliates from Armand and ArmaKleen in the third quarter of 2017 and 2016. The Corporate segment income before income taxes was $2.7 in the third quarter of 2017, as compared to $2.5 in the same period in 2016. The Corporate segment income before income taxes was $7.9 for the first nine months of 2017, as compared to $6.7 in the same period in 2016.

### Liquidity and Capital Resources

As of September 30, 2017, the Company had $236.5 in cash and cash equivalents, approximately $681.0 available through the revolving facility under its principal credit agreement (the “Credit Agreement”) and its commercial paper program, and a commitment increase feature under the Credit Agreement that enables the Company to borrow up to an additional $600.0, subject to lending commitments of the participating lenders and certain conditions as described in the Credit Agreement. To preserve its liquidity, the Company invests its cash primarily in government money market funds, prime money market funds, short-term commercial paper and short-term bank deposits.

The Company financed the Waterpik Acquisition with a portion of the proceeds from an underwritten public offering of $1,425.0 aggregate principal amount of Senior Notes completed on July 25, 2017, consisting of $300.0 aggregate principal amount of Floating Rate Senior Notes due 2019, $300.0 aggregate principal amount of 2.45% Senior Notes due 2022, $425.0 aggregate principal amount of 3.15% Senior Notes due 2027 and $400.0 aggregate principal amount of 3.95% Senior Notes due 2047 (collectively, the “Senior Notes”). The Floating Rate Senior Notes will bear interest at a rate, reset quarterly, equal to three-month U.S. dollar London Interbank Offered Rate (“LIBOR”) plus 0.15%. The remaining proceeds of the offering of the Senior Notes were used to pay down in its entirety and terminate the Company’s $200.0 term loan borrowed in the second quarter of 2017 and to repay a portion of the Company’s outstanding commercial paper borrowings.

The current economic environment presents risks that could have adverse consequences for the Company’s liquidity. (See “Unfavorable economic conditions could adversely affect demand for the Company’s products” under “Risk Factors” in Item 1A of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2016 (the “Form 10-K”.) The Company does not anticipate that current economic conditions will adversely affect its ability to comply with the financial covenant in the Credit Agreement because the Company currently is, and anticipates that it will continue to be, in compliance with the maximum leverage ratio requirement under the Credit Agreement.

On February 7, 2017, the Board declared a 7% increase in the regular quarterly dividend from $0.1775 to $0.19 per share, equivalent to an annual dividend of $0.76 per share payable to stockholders of record as of February 21, 2017. The increase raises the annual dividend payout from $183 to approximately $195, and maintains the Company’s payout of dividends relative to net income at approximately 40%.

In connection with the Company’s share repurchase program authorized by the Board in November 2016 (the “2016 Share Repurchase Program”) and its evergreen repurchase program, the Company purchased approximately 6.0 million shares in the first nine months of 2017 at a cost of approximately $300.0, of which approximately $125.0 was purchased under the evergreen share repurchase program and $175.0 was purchased under the 2016 Share Repurchase Program. On November 1, 2017, the Board authorized a new share repurchase program, under which the Company may repurchase up to $500.0 in shares of Common Stock (the “2017 Share Repurchase Program”). The 2017 Share Repurchase Program will replace the 2016 Share Repurchase Program. The Company will continue its evergreen share repurchase program.

The Company anticipates that its cash from operations, together with its current borrowing capacity, will be sufficient to meet its capital expenditure program costs, which are expected to be a total of approximately $45.0 in 2017, fund its share repurchase programs to the extent implemented by management and pay dividends at the latest approved rate. Cash, together with the Company’s current borrowing capacity, may be used for acquisitions that would complement the Company’s existing product lines or geographic markets. The Company does not have any mandatory debt principal payments in 2017 or 2018.

#### Cash Flow Analysis

|  | Nine Months Ended September 30, 2017 | September 30, 2016 |
| --- | ---: | ---: |
| Net cash provided by operating activities | **$424.1** | $495.0 |
| Net cash used in investing activities | **$(1,278.3)** | $(202.8) |
| Net cash provided by (used in) financing activities | **$888.6** | $(392.7) |

**Net Cash Provided by Operating Activities –** The Company’s primary source of liquidity is the strong cash flow provided by operating activities, which is dependent on the level of net income and changes in working capital. The Company’s net cash provided by operating activities in the nine months ended September 30, 2017 decreased by $70.9 to $424.1 as compared to $495.0 in the same period in 2016 due to an increase in working capital, partially offset by higher cash earnings (net income plus non-cash expenses such as depreciation, amortization, non-cash compensation and asset impairment charges). The change in working capital is primarily due to a large decrease in accounts payable and accrued expenses due to changes in deferred compensation, incentive compensation and profit sharing payments and larger increases in inventory and accounts receivable. However, the Company measures working capital effectiveness based on its cash conversion cycle. The following table presents the Company’s cash conversion cycle information for the quarters ended September 30, 2017 and 2016:

|  | As of September 30, 2017 | September 30, 2016 | Change |
| --- | ---: | ---: | ---: |
| Days of sales outstanding in accounts receivable ("DSO") | 31 | 28 | 3 |
| Days of inventory outstanding ("DIO") | 53 | 54 | (1) |
| Days of accounts payable outstanding ("DPO") | 69 | 60 | (9) |
| Cash conversion cycle | 15 | 22 | (7) |

The Company's cash conversion cycle (defined as the sum of DSO and DIO less DPO) which is calculated using a 2 period average method, improved 7 days from the prior year amount of 22 days to 15 days at September 30, 2017 due primarily to improved DPO of 9 days as the Company continues to extend payment terms with its suppliers. DIO improved 1 day from 54 to 53 days, offset by DSO which increased 3 days from 28 to 31 days. The improvement in the Company's cash conversion cycle reflects the Company's continued focus on reducing its average working capital requirements.

**Net Cash Used in Investing Activities –** Net cash used in investing activities during the first nine months of 2017 was $1,278.3, primarily reflecting $1,024.7 for the Waterpik Acquisition, $160.3 for the Viviscal Acquisition, $75.0 for the Agro Acquisition and $20.9 for property, plant and equipment expenditures, partially offset by $4.5 of cash proceeds from the sale of the Brazil chemical business. Net cash used in investing activities during the first nine months of 2016 was $202.8, principally reflecting $175.5 for the acquisition of Spencer Forrest, Inc., the maker of TOPPIK and $28.1 for property, plant and equipment expenditures.

**Net Cash Provided by (Used in) Financing Activities –** Net cash provided by financing activities during the first nine months of 2017 was $888.6, primarily reflecting $1,621.3 of long-term debt borrowings and $37.9 of proceeds from stock option exercises partially offset by $300.0 of repurchases of the Company’s Common Stock, $200.0 of long-term debt repayments, $143.2 of cash dividend payments, $105.0 of net commercial paper repayments, $17.8 of financing costs and $4.6 of short-term debt repayments at an international subsidiary. Net cash used in financing activities during the first nine months of 2016 was $392.7, primarily reflecting $200.0 of repurchases of the Company’s Common Stock, $137.4 of cash dividend payments and repayment of $131.3 of commercial paper borrowings, offset by $77.4 of proceeds and tax benefits from stock option exercises and $4.2 of short term borrowings at an international subsidiary.

## Market risk

As filed, 346 characters.

### Market risk

For quantitative and qualitative disclosures about market risk affecting the Company, see “Quantitative and Qualitative Disclosures About Market Risk” in Item 7A of Part II of our Annual Report on Form 10-K for the fiscal year ended December 31, 2016. Our exposure to market risk has not changed materially since December 31, 2016.

## Controls and procedures

As filed, 5,623 characters.

a) Evaluation of Disclosure Controls and Procedures

The Company’s management, with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) at the end of the period covered by this report. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures, as of the end of the period covered by this report, are effective to provide reasonable assurance that the information required to be disclosed by the Company in reports filed under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified in the rules and forms of the United States Securities and Exchange Commission (the “Commission”), and (ii) accumulated and communicated to the Company’s management, including the Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding the disclosure.

b) Change in Internal Control over Financial Reporting

On August 7, 2017, the Company completed the Waterpik Acquisition. The Company is in the process of integrating Waterpik and the Company’s internal controls over financial reporting. As a result of the integration activities, certain controls will be evaluated and may be changed. The SEC’s rules require us to include acquired entities in our assessment of the effectiveness of internal control over financial reporting no later than the annual management report following the first anniversary of the acquisition. Excluding the Waterpik Acquisition, there were no changes in the Company’s internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) occurring during the Company’s most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

### CAUTIONARY NOTE ON FORWARD-LOOKING INFORMATION

This report contains forward-looking statements, including, among others, statements relating to net sales and earnings growth; gross margin changes; trade and marketing spending; marketing expense as a percentage of net sales; sufficiency of cash flows from operations; earnings per share; the impact of new accounting pronouncements; the valuation of its indefinite lived intangible assets; cost savings programs; consumer demand and spending; the effects of competition; the effect of product mix; volume growth, including the effects of new product launches into new and existing categories; the impact of competitive laundry detergent products; the impact of foreign exchange and commodity price fluctuations; the Company’s investments in joint ventures; the impact of acquisitions and divestitures; the consummation, financing and impact of the Waterpik Acquisition; capital expenditures; pension settlement charges; the Company’s share repurchase programs and the Company’s effective tax rate. These statements represent the intentions, plans, expectations and beliefs of the Company, and are based on assumptions that the Company believes are reasonable but may prove to be incorrect. In addition, these statements are subject to risks, uncertainties and other factors, many of which are outside the Company’s control and could cause actual results to differ materially from such forward-looking statements. Factors that could cause such differences include a decline in market growth, retailer distribution and consumer demand (as a result of, among other things, political, economic and marketplace conditions and events); unanticipated increases in raw material and energy prices; delays or other problems in manufacturing or distribution; adverse developments affecting the financial condition of major customers and suppliers; competition, including The Procter & Gamble Company’s participation in the value laundry detergent category and Henkel’s entry into the U.S. premium laundry detergent category; Henkel’s acquisition of Sun Products; changes in marketing and promotional spending; growth or declines in various product categories and the impact of customer actions in response to changes in consumer demand and the economy, including increasing shelf space of private label products; consumer and competitor reaction to, and customer acceptance of, new product introductions and features; the Company’s ability to maintain product quality and characteristics at a level acceptable to our customers and consumers; disruptions in the banking system and financial markets; foreign currency exchange rate fluctuations; implications of the United Kingdom’s withdrawal from the European Union; issues relating to the Company’s information technology and controls; the impact of natural disasters on the Company and its customers and suppliers, including third party information technology service providers; the acquisition or divestiture of assets; the outcome of contingencies, including litigation, pending regulatory proceedings and environmental matters; and changes in the regulatory environment.

The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by the U. S. federal securities laws. You are advised, however, to consult any further disclosures the Company makes on related subjects in its filings with the Commission.

## Risk factors

As filed, 252 characters.

In addition to the other information set forth in this report, you should carefully consider the factors discussed in Item 1A, “Risk Factors” in the Form 10-K, which could materially affect the Company’s business, financial condition or future results.

Filed Nov 2, 2017.
Source: SEC EDGAR, the filing index for accession 0001564590-17-021066. Last ingested by Listed: Nov 14, 2026, 21:34 ET. No prices; not investment advice.
